S&P 500   3,364.58 (-0.46%)
DOW   29,208.70 (-0.64%)
QQQ   234.17 (-0.20%)
AAPL   317.88 (-2.18%)
FB   217.77 (+1.68%)
MSFT   186.93 (+0.85%)
GOOGL   1,521.90 (+0.21%)
AMZN   2,144.08 (+0.43%)
CGC   22.19 (+0.27%)
NVDA   292.24 (+0.85%)
BABA   218.53 (-0.50%)
MU   57.77 (-1.25%)
GE   12.83 (+0.00%)
TSLA   847.49 (+5.93%)
AMD   56.54 (+2.21%)
NFLX   387.59 (+1.89%)
PRI   135.01 (-1.34%)
BAC   34.32 (-1.55%)
DIS   138.40 (-0.82%)
GILD   67.23 (-0.49%)
S&P 500   3,364.58 (-0.46%)
DOW   29,208.70 (-0.64%)
QQQ   234.17 (-0.20%)
AAPL   317.88 (-2.18%)
FB   217.77 (+1.68%)
MSFT   186.93 (+0.85%)
GOOGL   1,521.90 (+0.21%)
AMZN   2,144.08 (+0.43%)
CGC   22.19 (+0.27%)
NVDA   292.24 (+0.85%)
BABA   218.53 (-0.50%)
MU   57.77 (-1.25%)
GE   12.83 (+0.00%)
TSLA   847.49 (+5.93%)
AMD   56.54 (+2.21%)
NFLX   387.59 (+1.89%)
PRI   135.01 (-1.34%)
BAC   34.32 (-1.55%)
DIS   138.40 (-0.82%)
GILD   67.23 (-0.49%)
S&P 500   3,364.58 (-0.46%)
DOW   29,208.70 (-0.64%)
QQQ   234.17 (-0.20%)
AAPL   317.88 (-2.18%)
FB   217.77 (+1.68%)
MSFT   186.93 (+0.85%)
GOOGL   1,521.90 (+0.21%)
AMZN   2,144.08 (+0.43%)
CGC   22.19 (+0.27%)
NVDA   292.24 (+0.85%)
BABA   218.53 (-0.50%)
MU   57.77 (-1.25%)
GE   12.83 (+0.00%)
TSLA   847.49 (+5.93%)
AMD   56.54 (+2.21%)
NFLX   387.59 (+1.89%)
PRI   135.01 (-1.34%)
BAC   34.32 (-1.55%)
DIS   138.40 (-0.82%)
GILD   67.23 (-0.49%)
S&P 500   3,364.58 (-0.46%)
DOW   29,208.70 (-0.64%)
QQQ   234.17 (-0.20%)
AAPL   317.88 (-2.18%)
FB   217.77 (+1.68%)
MSFT   186.93 (+0.85%)
GOOGL   1,521.90 (+0.21%)
AMZN   2,144.08 (+0.43%)
CGC   22.19 (+0.27%)
NVDA   292.24 (+0.85%)
BABA   218.53 (-0.50%)
MU   57.77 (-1.25%)
GE   12.83 (+0.00%)
TSLA   847.49 (+5.93%)
AMD   56.54 (+2.21%)
NFLX   387.59 (+1.89%)
PRI   135.01 (-1.34%)
BAC   34.32 (-1.55%)
DIS   138.40 (-0.82%)
GILD   67.23 (-0.49%)
Log in

NASDAQ:RPTP - Raptor Pharmaceutical Stock Price, Forecast & News

Notice: This company has been marked as potentially delisted and may not be actively trading.
Add
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
VolumeN/A
Average Volume1.42 million shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Raptor Pharmaceutical Corp. (Raptor) is a biopharmaceutical company. The Company is focused on developing and commercializing transformative treatments for people affected by diseases. Its product, PROCYSBI (cysteamine bitartrate) is a delayed-release capsules for the management of nephropathic cystinosis in adults and children of over six years. In Europe, PROCYSBI gastro-resistant hard capsules of cysteamine (as mercaptamine bitartrate), is indicated as an orphan medicinal product for the management of nephropathic cystinosis. Read More…

Industry, Sector and Symbol

Industry N/A
Sub-IndustryBiotechnology
SectorN/A
Current SymbolNASDAQ:RPTP
CUSIP75382F10
Phone+1-415-4086200

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableOptionable

Receive RPTP News and Ratings via Email

Sign-up to receive the latest news and ratings for RPTP and its competitors with MarketBeat's FREE daily newsletter.


Raptor Pharmaceutical (NASDAQ:RPTP) Frequently Asked Questions

What is Raptor Pharmaceutical's stock symbol?

Raptor Pharmaceutical trades on the NASDAQ under the ticker symbol "RPTP."

Has Raptor Pharmaceutical been receiving favorable news coverage?

News articles about RPTP stock have been trending extremely negative recently, according to InfoTrie. The research firm scores the sentiment of news coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Raptor Pharmaceutical earned a news sentiment score of -5.0 on InfoTrie's scale. They also assigned news headlines about the biotechnology company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the stock's share price in the next few days. View News Stories for Raptor Pharmaceutical.

Who are some of Raptor Pharmaceutical's key competitors?

What other stocks do shareholders of Raptor Pharmaceutical own?

What is Raptor Pharmaceutical's official website?

The official website for Raptor Pharmaceutical is http://www.horizonpharma.com/.

How can I contact Raptor Pharmaceutical?

Raptor Pharmaceutical's mailing address is 7 Hamilton Lndg Ste 100, NOVATO, CA 94949-8283, United States. The biotechnology company can be reached via phone at +1-415-4086200.


MarketBeat Community Rating for Raptor Pharmaceutical (NASDAQ RPTP)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  262 (Vote Outperform)
Underperform Votes:  276 (Vote Underperform)
Total Votes:  538
MarketBeat's community ratings are surveys of what our community members think about Raptor Pharmaceutical and other stocks. Vote "Outperform" if you believe RPTP will outperform the S&P 500 over the long term. Vote "Underperform" if you believe RPTP will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/18/2020 by MarketBeat.com Staff

Featured Article: Forex

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel